Banks Healthcare Sector

Pacira BioSciences

Market Cap: US$1.2b

Engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States.

Kestra Medical Technologies

Market Cap: US$1.2b

Operates as a wearable medical device and digital healthcare company.

SS Innovations International

Market Cap: US$1.2b

Operates as a commercial-stage surgical robotics company in India and internationally.

ANI Pharmaceuticals

Market Cap: US$1.2b

A biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.

Pediatrix Medical Group

Market Cap: US$1.2b

Provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States.

U.S. Physical Therapy

Market Cap: US$1.1b

Operates and manages outpatient physical therapy clinics.

Dynavax Technologies

Market Cap: US$1.1b

A commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally.

Neuren Pharmaceuticals

Market Cap: AU$1.8b

A biopharmaceutical company, develops drugs for the treatment of neurological disorders.

Natus Medical

Market Cap: US$1.1b

Natus Medical Incorporated provides medical device solutions focuses on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide.

Novavax

Market Cap: US$1.1b

A biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally.

Viridian Therapeutics

Market Cap: US$1.1b

Engages in discovering, developing, and commercializing treatments for serious and rare diseases.

10x Genomics

Market Cap: US$1.1b

A life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific.

Aurinia Pharmaceuticals

Market Cap: US$1.1b

A biopharmaceutical company that engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs.

BioLife Solutions

Market Cap: US$1.1b

Develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.

Spire Healthcare Group

Market Cap: UK£778.2m

Owns and operates private hospitals and clinics in the United Kingdom.

Establishment Labs Holdings

Market Cap: US$1.0b

A medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgeries.

Aveanna Healthcare Holdings

Market Cap: US$1.0b

A diversified home care platform company, provides pediatric and adult healthcare services in the United States.

Mineralys Therapeutics

Market Cap: US$1.0b

A clinical-stage biopharmaceutical company, develops medicines to target diseases driven by dysregulated aldosterone in the United States.

OPKO Health

Market Cap: US$1.0b

A healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally.

Oculis Holding

Market Cap: US$1.0b

A clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic diseases in Switzerland, Iceland, and internationally.

Intellia Therapeutics

Market Cap: US$1.0b

A clinical-stage gene editing company, focuses on the development of curative genome editing treatments.

CureVac

Market Cap: US$999.7m

A biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA).

Phibro Animal Health

Market Cap: US$993.1m

Operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally.

Integra LifeSciences Holdings

Market Cap: US$986.9m

Manufactures and sells surgical instrument, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology.

Craneware

Market Cap: UK£724.9m

Develops, licenses, and supports computer software for the healthcare industry in the United States.

CareDx

Market Cap: US$977.8m

Engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally.

agilon health

Market Cap: US$972.8m

Provides healthcare services for seniors through primary care physicians in the communities of the United States.

Arcus Biosciences

Market Cap: US$966.7m

A clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States.

MiMedx Group

Market Cap: US$961.5m

Develops and distributes placental tissue allografts for various sectors of healthcare.

Pennant Group

Market Cap: US$960.3m

Provides healthcare services in the United States.

NeoGenomics

Market Cap: US$954.9m

Operates a network of cancer-focused testing laboratories in the United States and the United Kingdom.

Harrow

Market Cap: US$951.3m

An eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products.

Ardelyx

Market Cap: US$935.5m

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.

Wave Life Sciences

Market Cap: US$932.5m

A clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform.

Collegium Pharmaceutical

Market Cap: US$929.2m

A specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.

Geron

Market Cap: US$923.5m

A commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.